BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2900483)

  • 21. Alprazolam in clinically anxious patients with depressed mood.
    Aden GC
    J Clin Psychiatry; 1983 Jan; 44(1):22-4. PubMed ID: 6130082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in anxiolytic therapy.
    Rickels K
    J Clin Psychiatry; 1981 Nov; 42(11 Pt 2):40-4. PubMed ID: 6120938
    [No Abstract]   [Full Text] [Related]  

  • 23. [Double-blind controlled trial comparing alprazolam and lorazepam in ambulatory anxious patients].
    Hecquet S; Puech AJ; Lecrubier Y
    Therapie; 1984; 39(3):253-61. PubMed ID: 6147031
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder.
    Cohn JB; Wilcox CS
    Pharmacotherapy; 1984; 4(2):93-8. PubMed ID: 6144090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study.
    Chouinard G; Annable L; Fontaine R; Solyom L
    Psychopharmacology (Berl); 1982; 77(3):229-33. PubMed ID: 6126907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind clinical assessment of alprazolam, a new benzodiazepine derivative, in the treatment of moderate to severe anxiety.
    Greiss KC; Fogari R
    J Clin Pharmacol; 1980; 20(11):693-9. PubMed ID: 6112245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
    Maletzky BM
    J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the effect of two benzodiazepines in the treatment of anxious outpatients.
    de Figueiredo R; Franchini A; Martinho A; Hindmarch I
    Int Pharmacopsychiatry; 1981; 16(1):57-65. PubMed ID: 6117537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal profile of brain response to alprazolam in patients with generalized anxiety disorder.
    Brown GG; Ostrowitzki S; Stein MB; von Kienlin M; Liu TT; Simmons A; Wierenga C; Stein OY; Bruns A; Bischoff-Grethe A; Paulus M
    Psychiatry Res; 2015 Sep; 233(3):394-401. PubMed ID: 26211623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the efficacy and tolerability of clobazam and chlordiazepoxide in the treatment of acute withdrawal from alcohol in patients with primary alcoholism.
    Mukherjee PK
    J Int Med Res; 1983; 11(4):205-11. PubMed ID: 6137426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
    Davison K; Farquharson RG; Khan MC; Majid A
    Br J Clin Pharmacol; 1985; 19 Suppl 1(Suppl 1):37S-43S. PubMed ID: 2859877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Double-blind study of clobazam (Odipam) and diazepam in non-psychotic anxiety states].
    Ostrogonac S; Vuckovic S
    Med Pregl; 1989; 42(1-2):19-21. PubMed ID: 2569665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing.
    Anhalt HS; Young R; Roginsky M
    J Clin Psychiatry; 1980 Nov; 41(11):386-92. PubMed ID: 6108319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Dawson GW; Jue SG; Brogden RN
    Drugs; 1984 Feb; 27(2):132-47. PubMed ID: 6141930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alprazolam-reinforced medication use in outpatients with anxiety.
    Roache JD; Stanley MA; Creson DR; Shah NN; Meisch RA
    Drug Alcohol Depend; 1997 May; 45(3):143-55. PubMed ID: 9179516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clobazam and panic disorder.
    J Clin Psychiatry; 1991 Jan; 52(1):44. PubMed ID: 1671033
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.
    Lydiard RB; Rickels K; Herman B; Feltner DE
    Int J Neuropsychopharmacol; 2010 Mar; 13(2):229-41. PubMed ID: 19737439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group.
    Möller HJ; Volz HP; Reimann IW; Stoll KD
    J Clin Psychopharmacol; 2001 Feb; 21(1):59-65. PubMed ID: 11199949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.